TY - BOOK PY - 2018 UR - http://hdl.handle.net/10668/4221 T2 - Informe de evaluación de medicamentos AB - En este informe de la European Network for Health Technology Assessment (EUnetHTA), se evalúa la eficacia y seguridad relativas de alectinib, en comparación con crizotinib y ceritinib, en el tratamiento de primera línea en pacientes adultos con cáncer... LA - spa PB - Agencia de Evaluación de Tecnologías Sanitarias de Andalucía, Consejería de Salud, Junta de Andalucía KW - Carcinoma pulmonar de células no pequeñas KW - Tratamiento farmacológico KW - Neoplasias pulmonares KW - Quimioterapia KW - Evaluación de medicamentos KW - Quinasa de linfoma anaplásico KW - Terapéutica KW - Adulto KW - Carcinoma, non-small-cell lung KW - Drug therapy KW - Lung neoplasms KW - Drug evaluation KW - Anaplastic lymphoma kinase KW - Therapeutics KW - Adult KW - Medical Subject Headings::Diseases::Neoplasms::Neoplasms by Site::Thoracic Neoplasms::Respiratory Tract Neoplasms::Lung Neoplasms KW - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy KW - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Evaluation Studies as Topic::Drug Evaluation KW - Medical Subject Headings::Diseases::Neoplasms::Neoplasms by Site::Thoracic Neoplasms::Respiratory Tract Neoplasms::Lung Neoplasms::Bronchial Neoplasms::Carcinoma, Bronchogenic::Carcinoma, Non-Small-Cell Lung KW - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy KW - Medical Subject Headings::Diseases::Neoplasms::Neoplasms by Site::Thoracic Neoplasms::Respiratory Tract Neoplasms::Lung Neoplasms KW - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Evaluation Studies as Topic::Drug Evaluation KW - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics KW - Medical Subject Headings::Persons::Persons::Age Groups::Adult TI - Alectinib en primera línea de tratamiento en pacientes adultos con carcinoma de pulmón no microcítico avanzado ALK positivo TY - book ER -